Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIDEA.L Regulatory News (IDEA)

  • There is currently no data for IDEA

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Dealings and Total Voting Rights

20 Nov 2019 11:58

RNS Number : 0865U
Ideagen PLC
20 November 2019
 

Ideagen PLC

("Ideagen," "the Company" or the "Group'')

Director/PDMR Dealings and Total Voting Rights

Ideagen PLC (AIM: IDEA), a leading supplier of Information Management Software to highly regulated industries, announces the following dealings in ordinary shares of 1p each in the capital of the Company ("Ordinary Shares") by certain directors and PDMRs of the Company:

Name

Position

Dealing

Number of Ordinary Shares

Exercise/Dealing price (pence)

Graeme Spenceley

Chief Financial Officer

Exercise of share options

800,000

9.00

Graeme Spenceley

Chief Financial Officer

Exercise of share options

795,000

22.38

Barnaby Kent

Chief Operating Officer

Exercise of share options

1,000,000

22.38

Graeme Spenceley

Chief Financial Officer

Sale of Ordinary Shares

190,000

150.00

Barnaby Kent

Chief Operating Officer

Sale of Ordinary Shares

170,000

150.00

Alex Hewitt

Chief Legal Officer (PDMR)

Purchase of Ordinary Shares

126,000

150.00

Mr Spenceley and Mr Kent's sales of Ordinary Shares were to cover the option exercise costs and associated taxation. As a result of the transactions listed above Mr Spenceley and Mr Kent's beneficial interests in Ordinary Shares have increased by 1,405,000 and 830,000 respectively. The resultant shareholdings of Messrs Spenceley, Kent and Hewitt are as follows:

Name

Beneficial interest in Ordinary Shares

Percentage of total voting rights of the Company (%)

Graeme Spenceley

2,234,595

0.99

Barnaby Kent

3,109,535

1.37

Alex Hewitt

131,750

0.06

Application has been made to the London Stock Exchange for the 2,595,000 new Ordinary Shares to be admitted to trading on AIM ("Admission") and it is expected that Admission will become effective and trading will commence at 8.00 a.m. on 26 November 2019.

After Admission, the total number of Ordinary Shares in issue will be 226,187,708 and the total number of voting rights will therefore be 226,187,708. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

The information communicated in this announcement includes inside information for the purposes of Article 7 of Regulation 596/2014 

Enquiries:

Ideagen plc

01629 699100

David Hornsby, Executive Chairman

Ben Dorks, Chief Executive

Graeme Spenceley, Finance Director

finnCap Limited

020 7220 0500

Henrik Persson/James Thompson (Nomad)

Alice Lane (ECM)

Canaccord Genuity

020 7523 8000

Simon Bridges

Richard Andrews

 About Ideagen plc

Ideagen is a UK-headquartered, global technology company quoted on the London Stock Exchange AIM market (Ticker: IDEA.L).

The Group provides IRM software and services to organisations operating within highly regulated industries such as aviation, banking and finance and life science, with its main operational premises spread throughout the UK, EU, US, Middle East and SE Asia.

With an excellent portfolio of software products including Q-Pulse, Coruson, Pentana Audit and PleaseReview, Ideagen helps its clients reduce costs, improve operational efficiency, strengthen compliance and oversight and anticipate and manage every detail of risk.

Currently, more than 4,700 organisations use Ideagen's products including seven of the top 10 UK accounting firms, all of the top aerospace and defence companies and 75% of the world's leading pharmaceutical firms.

Ideagen's diverse and varied customer base includes many well-known, global brands such as British Airways, Aggreko, BAE, Ryanair, US Navy, KLM, BBVA, Bank of New York, Commerzbank, Meggitt, Heineken, Johnson Matthey, Haeco Group and European Central Bank. As well as this, Ideagen counts 180 hospitals across the UK and US amongst its client base.

For further information please visit www.ideagen.com

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Graeme Spenceley

2.

Reason for the Notification

a)

Position/status

CFO

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Ideagen plc

b)

LEI

213800KS1MLITOVNYC85

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary Shares of 1p each

Identification code

GB00B0CM0C50

b)

Nature of the transaction

Exercise of Options over Ordinary Shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

9p

800,000

22.38p

795,000

d)

Aggregated information:

·; Aggregated volume

·; Price

 

1,595,000 options over ordinary shares of 1p each exercised

e)

Date of the transaction

20 November 2019

f)

Place of the transaction

Off market transaction

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Graeme Spenceley

2.

Reason for the Notification

a)

Position/status

CFO

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Ideagen plc

b)

LEI

213800KS1MLITOVNYC85

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary Shares of 1p each

Identification code

GB00B0CM0C50

b)

Nature of the transaction

Sale of Ordinary Shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

150p

190,000

d)

Aggregated information:

·; Aggregated volume

·; Price

 

190,000 ordinary shares of 1p each sold at 150 pence each

e)

Date of the transaction

20 November 2019

f)

Place of the transaction

London Stock Exchange AIM (XLON)

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Barnaby Kent

2.

Reason for the Notification

a)

Position/status

COO

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Ideagen plc

b)

LEI

213800KS1MLITOVNYC85

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary Shares of 1p each

Identification code

GB00B0CM0C50

b)

Nature of the transaction

Exercise of Options over Ordinary Shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

22.38p

1,000,000

d)

Aggregated information:

·; Aggregated volume

·; Price

 

1,000,000 options over ordinary shares of 1p each exercised

e)

Date of the transaction

20 November 2019

f)

Place of the transaction

Off market transaction

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Barnaby Kent

2.

Reason for the Notification

a)

Position/status

COO

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Ideagen plc

b)

LEI

213800KS1MLITOVNYC85

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary Shares of 1p each

Identification code

GB00B0CM0C50

b)

Nature of the transaction

Sale of Ordinary Shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

150p

170,000

d)

Aggregated information:

·; Aggregated volume

·; Price

 

170,000 ordinary shares of 1p each sold at 150 pence each

e)

Date of the transaction

20 November 2019

f)

Place of the transaction

London Stock Exchange AIM (XLON)

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Alex Hewitt

2.

Reason for the Notification

a)

Position/status

Chief Legal Officer

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Ideagen plc

b)

LEI

213800KS1MLITOVNYC85

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary Shares of 1p each

Identification code

GB00B0CM0C50

b)

Nature of the transaction

Purchase of Ordinary Shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

150p

126,000

d)

Aggregated information:

·; Aggregated volume

·; Price

 

126,000 ordinary shares of 1p each purchased at 150 pence each

e)

Date of the transaction

20 November 2019

f)

Place of the transaction

London Stock Exchange AIM (XLON)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHKMMZMMGVGLZM
Date   Source Headline
14th Oct 20215:46 pmRNSIssue of new shares under the SIP
14th Oct 20217:00 amRNSSale of Pentana Compliance
11th Oct 20212:25 pmRNSNotice of AGM
1st Oct 20213:15 pmRNSTotal Voting Rights
1st Oct 20217:00 amRNSChange of Auditor
24th Sep 20219:37 amRNSIssue of Shares, PDMR Dealing & TVR
13th Sep 20214:50 pmRNSExercise of Options and Total Voting Rights
10th Sep 20216:05 pmRNSHolding(s) in Company
2nd Sep 20217:00 amRNSTotal Voting Rights
31st Aug 20219:32 amRNSHolding(s) in Company
26th Aug 20217:00 amRNSPDMR Dealing and Total Voting Rights
11th Aug 20212:02 pmRNSIssue of new shares under the SIP and TVR
11th Aug 20217:00 amRNSExercise of Options and Total Voting Rights
23rd Jul 20214:54 pmRNSPDMR Dealing and Total Voting Rights
22nd Jul 20217:00 amRNSFinal Results
20th Jul 20212:03 pmRNSIssue of new shares under the SIP
19th Jul 20217:00 amRNSTwo highly complementary strategic acquisitions
15th Jul 20214:17 pmRNSExercise of share options and Total Voting Rights
16th Jun 20217:00 amRNSIssue of new shares under the SIP
10th Jun 20214:41 pmRNSSecond Price Monitoring Extn
10th Jun 20214:36 pmRNSPrice Monitoring Extension
21st May 20217:00 amRNSDirector/PDMR Shareholding
13th May 20217:00 amRNSPre-Close Trading Update and Board Change
28th Apr 20217:00 amRNSDirector Dealings and Total Voting Rights
14th Apr 202112:40 pmRNSIssue of Shares, PDMR Dealing & TVR
16th Mar 20213:33 pmRNSIssue of new shares under the SIP and TVR
9th Mar 20217:00 amRNSAcquisition of Qualtrax
26th Feb 20211:49 pmRNSHolding(s) in Company
25th Feb 20214:00 pmRNSHolding(s) in Company
25th Feb 20217:00 amRNSHolding(s) in Company
23rd Feb 20217:00 amRNSPDMR Dealing and Total Voting Rights
16th Feb 20215:15 pmRNSIssue of Equity & Total Voting Rights
12th Feb 20217:00 amRNSDirector/PDMR Dealings
3rd Feb 20219:35 amRNSExtension to 2018 LTIP Awards
26th Jan 20217:00 amRNSSuccession of Chairman
26th Jan 20217:00 amRNSUnaudited Interim Results
25th Jan 20214:26 pmRNSH1 Results Presentation
22nd Jan 20217:00 amRNSHolding(s) in Company
31st Dec 20207:00 amRNSHolding(s) in Company
31st Dec 20207:00 amRNSHolding(s) in Company
30th Dec 20207:21 amRNSCompletion of Huddle Acquisition
23rd Dec 202011:30 amRNSAcquisition of Huddle
22nd Dec 20202:04 pmRNSHolding(s) in Company
18th Dec 202012:56 pmRNSIssue of Shares & Director/PDMR Shareholding
9th Dec 20207:00 amRNSResult of Placing and PrimaryBid Offer
8th Dec 20204:53 pmRNSPrimaryBid.com Offer
8th Dec 20204:50 pmRNSProposed Fundraise of £48.7 million
20th Nov 20203:40 pmRNSIssue of Equity, PDMR Dealing and TVR
17th Nov 202012:05 pmRNSChange of Registered Office
13th Nov 20203:51 pmRNSPDMR Shareholding and Exercise of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.